Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

157 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Resonant laser ionization and mass separation of 225Ac.
Johnson JD, Heines M, Bruchertseifer F, Chevallay E, Cocolios TE, Dockx K, Duchemin C, Heinitz S, Heinke R, Hurier S, Lambert L, Leenders B, Skliarova H, Stora T, Wojtaczka W. Johnson JD, et al. Among authors: bruchertseifer f. Sci Rep. 2023 Jan 24;13(1):1347. doi: 10.1038/s41598-023-28299-4. Sci Rep. 2023. PMID: 36693865 Free PMC article.
In Vivo evaluation of newly synthesized 213Bi-conjugated alpha-melanocyte stimulating hormone (α-MSH) peptide analogues in melanocortin-1 receptor (MC1-R) positive experimental melanoma model.
Kálmán-Szabó I, Képes Z, Fekete A, Vágner A, Nagy G, Szücs D, Gyuricza B, Arató V, Varga J, Kárpáti L, Garai I, Mándity I, Bruchertseifer F, Elek J, Szikra D, Trencsényi G. Kálmán-Szabó I, et al. Among authors: bruchertseifer f. J Pharm Biomed Anal. 2023 May 30;229:115374. doi: 10.1016/j.jpba.2023.115374. Epub 2023 Mar 28. J Pharm Biomed Anal. 2023. PMID: 37001274 Free article.
Actinium-225-PSMA radioligand therapy of metastatic castration-resistant prostate cancer (WARMTH Act): a multicentre, retrospective study.
Sathekge MM, Lawal IO, Bal C, Bruchertseifer F, Ballal S, Cardaci G, Davis C, Eiber M, Hekimsoy T, Knoesen O, Kratochwil C, Lenzo NP, Mahapane J, Maserumule LC, Mdlophane AH, Mokoala KMG, Ndlovu H, Pant V, Rathke H, Reed J, Sen IB, Singh A, Sood A, Tauber R, Thakral P, Yadav MP, Morgenstern A. Sathekge MM, et al. Among authors: bruchertseifer f. Lancet Oncol. 2024 Feb;25(2):175-183. doi: 10.1016/S1470-2045(23)00638-1. Epub 2024 Jan 11. Lancet Oncol. 2024. PMID: 38218192
Evaluation of the therapeutic efficacy of 213Bi-labelled DOTA-conjugated alpha-melanocyte stimulating hormone peptide analogues in melanocortin-1 receptor positive preclinical melanoma model.
Csikos C, Képes Z, Fekete A, Vágner A, Nagy G, Gyuricza B, Arató V, Kárpáti L, Mándity I, Bruchertseifer F, Halmos G, Szikra D, Trencsényi G. Csikos C, et al. Among authors: bruchertseifer f. Int J Pharm. 2023 Sep 25;644:123344. doi: 10.1016/j.ijpharm.2023.123344. Epub 2023 Aug 25. Int J Pharm. 2023. PMID: 37634663 Free article.
First preclinical evaluation of [225Ac]Ac-DOTA-JR11 and comparison with [177Lu]Lu-DOTA-JR11, alpha versus beta radionuclide therapy of NETs.
Handula M, Beekman S, Konijnenberg M, Stuurman D, de Ridder C, Bruchertseifer F, Morgenstern A, Denkova A, de Blois E, Seimbille Y. Handula M, et al. Among authors: bruchertseifer f. EJNMMI Radiopharm Chem. 2023 Jun 30;8(1):13. doi: 10.1186/s41181-023-00197-0. EJNMMI Radiopharm Chem. 2023. PMID: 37389800 Free PMC article.
157 results